KCM
PRTK

Kathmere Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Kathmere Capital Management’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-30,000
Closed -$66.3K – 281
2023
Q2 		$66.3K Hold
30,000
– – 0.01% 232
2023
Q1 		$76.2K Hold
30,000
– – 0.01% 220
2022
Q4 		$56.1K Buy
+30,000
New +$56.1K 0.01% 198